Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fulminant Anaphylaxis.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

World Allergy Organization survey on the diagnosis and management trends of perioperative anaphylaxis.

The World Allergy Organization journal·2026
Same author

More Than Moderate-Dose Inhaled Corticosteroid Therapy for Difficult-to-Treat Asthma: One Step Too Many?

The journal of allergy and clinical immunology. In practice·2025
Same author

Where is academic medicine going?: Part 2. Academic career and patient care.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2024
Same author

Where is academic medicine going?: Part 1. Medical education and research.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2024
Same author

Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee.

The World Allergy Organization journal·2024

Related Experiment Video

Updated: May 20, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Chapter 13: Potentially (near) fatal asthma.

Bradley R Sabin, Paul A Greenberger

    Allergy and Asthma Proceedings
    |July 17, 2012
    PubMed
    Summary

    Potentially fatal asthma (PFA) identifies high-risk patients needing aggressive monitoring and treatment. Early intervention and addressing non-pharmacological factors are key to managing this severe asthma subset.

    Area of Science:

    • Pulmonology
    • Critical Care Medicine
    • Asthma Research

    Background:

    • Potentially fatal asthma (PFA) represents a critical subset of asthma patients at high risk of mortality.
    • Recognizing PFA necessitates a more proactive approach to asthma management by healthcare providers and patients.

    Purpose of the Study:

    • To define the criteria for diagnosing potentially fatal asthma.
    • To outline the multifaceted treatment strategies for PFA, emphasizing early intervention and comprehensive care.

    Main Methods:

    • Diagnosis of PFA is based on specific clinical indicators: history of intubation, respiratory acidosis/failure, recurrent pneumothorax/pneumomediastinum, or frequent severe exacerbations despite optimal medical therapy.
    • Phenotyping of exacerbations into "subacute" and "hyperacute" provides insight into disease trajectory.

    Related Experiment Videos

    Last Updated: May 20, 2026

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
    14:39

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

    Published on: November 4, 2010

    Main Results:

    • Early intervention, ideally 3-7 days prior to a severe exacerbation, is crucial for effective management.
    • Optimizing asthma control involves reducing symptomatic days and rescue therapy use, particularly for "poor perceivers" of their condition.

    Conclusions:

    • Effective PFA management requires a comprehensive strategy beyond pharmacotherapy, including addressing adherence, psychiatric, and socioeconomic factors.
    • Physicians must recognize the limitations of current pharmacotherapies, including combination inhalers, in managing PFA.